Precigen Inc at JPMorgan Healthcare Conference Transcript
&-
Good afternoon and thanks for joining us for another session at the 42nd JPMorgan Healthcare Conference. I'm Brian Cheng. I'm one of the senior biotech analysts here. I'm joined by my associate, John Kim, who's in the audience. On stage, we have President and CEO, I'll pass the mike to Helen for a short presentation, followed by a Q&A either joining us live we can submit questions through the conference portal and if you're first joining us virtually and you can also submit a question as well online. Helen the stage is yours.
Thank you very much Brian. Thank you -for having us here, at JPMorgan this year. First of all, I may obviously would be making some forward-looking statements. So please make sure that you look at this slide in detail. With that, what I would like to be start with and about Precigen and what a transformative year we are going to have in front of us.
I think we are very excited about the strategy of Precigen,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
